We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Sysmex and Roche Extend Hematology Alliance

By LabMedica International staff writers
Posted on 17 Apr 2012
Print article
Sysmex Corporation (Kobe, Japan) and Roche (Basel, Switzerland) signed a restated 10 years distribution, sales, and services agreement (DSS Agreement). The previous distributorship, sales, and services agreement will extend for another 10 years.

Roche will continue to distribute Sysmex hematology products, including instruments, reagents, and data management solutions in selected countries and regions. These include Spain, Turkey, Greece, South Africa, Russia, Finland, Baltic Territory, Brazil, Mexico, Chile, Argentina, Uruguay, Colombia, Peru, Ecuador, Venezuela, Central America, Australia, and New Zealand.

The recently released new XN series from Sysmex with its modular and scalable system design enables customer access to a full menu across customer segments from small to large workloads. Concurrent with Roche’s future platform strategy, the new Sysmex XN series contributes to Roche’s concept of addressing the various needs of today’s laboratories with customized modular solutions. The renewed agreement allows both companies to apply their strengths more effectively.

Since entering into the DSS Agreement in 1999, Sysmex and Roche have combined their mutual strengths to expand market share while building a positive relationship.

Hisashi Ietsugu, president and CEO of Sysmex Corp. commented, "Based on Sysmex’ industry leadership allied with Roche’s unique position as the global market leader in in-vitro diagnostics, the collaboration underlines our objective of bringing a maximum of industry expertise in hematology to health professionals. This unique synergy supports both companies’ objectives to continue to grow above market."

Sysmex Corporation is a leader in clinical laboratory testing of blood, urine and other specimens, providing instruments and reagents for clinical laboratory testing as well as laboratory information systems as part of a comprehensive service and support system.

Roche Professional Diagnostics is Roche’s market-leading business area of integrated, modular, and highly efficient testing solutions for clinical and immune in vitro diagnostics for centralized and decentralized settings. Roche is also a leader in in-vitro diagnostics, tissue-based cancer diagnostics, and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life, and survival of patients.

Related Links:

Sysmex Corporation
Roche


Flocked Swab
HydraFlock and PurFlock Ultra
Gold Supplier
Colon Cancer Mutation Panel
UltraSEEK Colon Panel
New
3 Part Diff Auto Hematology Analyzer
HB7021
New
IFA Automation Solution
dIFine 30 System

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.